Active Cellular Growth Rushes the Market for Spine Biologics Market
The Spine Biologics Market is anticipated to reach USD USD 2.56 billion by 2021 from USD 2.07 billion in 2016, at a CAGR of 4.4%. The Global Spine Biologics Market is mainly driven by factors such as Increase in geriatric population, rise in the occurrence of diseases and increasing preference among surgeons.
View full press release